NANOG and cervical carcinoma: To investigate potential targets for impeding NANOG-driven autophagy in cisplatin-resistant tumor cells, we compared the expression of genes involved in EGFR hyperactivation among the genes upregulated by NANOG and highly expressed in chemotherapy-resistant cervical cancer patients (Fig. 4a).